Tisch Cancer Institute at Mount Sinai
2020 NSCLC Update: Does PD-L1 Predict Pembrolizumab Response in Patients With Both Squamous and Nonsquamous NSCLC?
By
Tisch Cancer Institute at Mount Sinai
FEATURING
Deborah Doroshow
By
Tisch Cancer Institute at Mount Sinai
FEATURING
Deborah Doroshow
Login to view comments.
Click here to Login
Videos